Several Winship faculty will present new clinical research results and clinical trial opportunities at the NRG Oncology semi-annual meeting to be held in Houston, January 9-11, 2020.
January 6, 2020
Several Winship faculty will present new clinical research results and new clinical trial opportunities at the NRG Oncology semi-annual meeting to be held in Houston, January 9-11, 2020. This meeting will have over 2,000 attendees and brings together investigators from across the globe to discuss the research conducted by NRG Oncology, which is the largest of the four clinical trials network groups supported by the National Cancer Institute (NCI).
Walter J. Curran, Jr., MD, FACR, FASCO, Winship executive director, Emory's Department of Radiation Oncology chairman, and NRG Oncology group chairman, will open the plenary session on Friday, January 10 with a summary of the group's work over the past six months. Kristin Higgins, MD, associate professor and radiation oncology medical director at Clifton campus, will present on NRG-LU005, the first NCI-supported randomized trial for limited stage small cell lung cancer patients in over a decade and a trial for which she serves as national principal investigator.
Winship member and Senior Vice President of Research at Emory University, Deborah W. Bruner, RN, PhD, FAAN is the NRG Oncology Community Oncology Research Program (NCORP) Research Base PI and will report on NRG's NCORP program during the plenary session.
As NRG Oncology Lung Cancer Committee Chair, Jeffrey Bradley, MD, FACR, FASTRO, will head the committee meeting on Saturday, January 11, 2020. The meeting will review ongoing and committee clinical trials and will develop strategies to increase participation in these trials at all institutions. Bradley will also present during the NRG Proton Working Group Meeting.
At the NRG Oncology Imaging Committee Meeting on Friday, Ashesh B. Jani, MD, MSEE, FASTRO will discuss the rationale for molecular imaging for men with primary high-risk prostate cancer and strategies for integrating molecular imaging hypotheses into the developing NRG GU-009 protocol.
Other Winship presenters include Mohammad K. Khan, MD, PhD, FACRO, who will present at the NRG Brain Tumor Workshop and the International Working Group on the "Phase III trial concept of Ipi/Nivo +SRS vs Ipi/Nivo +WBRT for melanoma patients with multiple brain metastases"; Nabil F. Saba, MD, FACP, who will discuss the general approach of using immunotherapy in earlier stage HNCA; and Jonathan J. Beitler, MD, MBA, FACR, FASTRO, who will present on "Protons versus TORS for early Oropharyngeal Cancer." Both Saba and Beitler will present at the NRG Head and Neck Surgical Sub-committee meeting and the Head and Neck Cancer Workshop.
Mylin A. Torres, MD was named one of three inaugural social media ambassadors for the meeting. Follow her and the other #NRG2020 Featured Voices on Twitter for updates while in Houston.